Literature DB >> 9311912

Negative regulation by HLA-DO of MHC class II-restricted antigen processing.

L K Denzin1, D B Sant'Angelo, C Hammond, M J Surman, P Cresswell.   

Abstract

HLA-DM is a major histocompatibility complex (MHC) class II-like molecule that facilitates antigen processing by catalyzing the exchange of invariant chain-derived peptides (CLIP) from class II molecules for antigenic peptides. HLA-DO is a second class II-like molecule that physically associates with HLA-DM in B cells. HLA-DO was shown to block HLA-DM function. Purified HLA-DM-DO complexes could not promote peptide exchange in vitro. Expression of HLA-DO in a class II+ and DM+, DO- human T cell line caused the accumulation of class II-CLIP complexes, indicating that HLA-DO blocked DM function in vivo and suggesting that HLA-DO is an important modulator of class II-restricted antigen processing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311912     DOI: 10.1126/science.278.5335.106

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  68 in total

1.  Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2DM.

Authors:  J A Villadangos; C Driessen; G P Shi; H A Chapman; H L Ploegh
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

Review 2.  The expression of HLA-DO (H2-O) in B lymphocytes.

Authors:  Xinjian Chen; Peter E Jensen
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  H2-O, a MHC class II-like protein, sets a threshold for B-cell entry into germinal centers.

Authors:  Nicole A Draghi; Lisa K Denzin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-31       Impact factor: 11.205

4.  DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms.

Authors:  Cornelia H Rinderknecht; Sujin Roh; Achal Pashine; Michael P Belmares; Namrata S Patil; Ning Lu; Phi Truong; Tieying Hou; Claudia Macaubas; Taejin Yoon; Nan Wang; Robert Busch; Elizabeth D Mellins
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

5.  LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens.

Authors:  Victoria L Crotzer; Nicole Glosson; Delu Zhou; Ichizo Nishino; Janice S Blum
Journal:  Immunology       Date:  2010-11       Impact factor: 7.397

6.  Cytomegalovirus infection enhances the immune response to influenza.

Authors:  David Furman; Vladimir Jojic; Shalini Sharma; Shai S Shen-Orr; Cesar J L Angel; Suna Onengut-Gumuscu; Brian A Kidd; Holden T Maecker; Patrick Concannon; Cornelia L Dekker; Paul G Thomas; Mark M Davis
Journal:  Sci Transl Med       Date:  2015-04-01       Impact factor: 17.956

Review 7.  Presentation of cytosolic antigens via MHC class II molecules.

Authors:  Delu Zhou; Janice S Blum
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

8.  A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM.

Authors:  Francis Deshaies; Alexandre Brunet; Djibril A Diallo; Lisa K Denzin; Angela Samaan; Jacques Thibodeau
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-22       Impact factor: 11.205

Review 9.  MHC class II molecules on the move for successful antigen presentation.

Authors:  Nuno Rocha; Jacques Neefjes
Journal:  EMBO J       Date:  2007-11-29       Impact factor: 11.598

Review 10.  MHC class II transport at a glance.

Authors:  Adam C Berger; Paul A Roche
Journal:  J Cell Sci       Date:  2009-01-01       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.